Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Nouri, Maryam Nabavi ^a   Ahmed, Ausma ^a   Bril, Vera ^a   Orszag, Andrej ^a   Ng, Eduardo ^a   Nwe, Patti ^a   Perkins, Bruce A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; AXON REFLEX NEUROGENIC VASODILATATION; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEUROPATHY; FEMALE; HUMAN; IMAGING SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; LASER DOPPLER IMAGING; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SENSORIMOTOR NEUROPATHY; SURAL NERVE; VASODILATATION;

ADULT; AXONS; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYNEUROPATHIES; REFLEX; ROC CURVE; VASODILATION; YOUNG ADULT;

EID: 84859826315     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034807     Document Type: Article

References (35)

1. Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, et al. (1989) Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 38: 1456-1461.
2. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, et al. (1990) Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39: 1116-1124.
3. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, et al. (1996) Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 39: 1377-1384.
4. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, et al. (2005) Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28: 956-962.
5. Dworkin RH, Malone DC, Panarites CJ, Armstrong EP, Pham SV, (2010) Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs. J Pain 11: 360-368.
6. Pambianco G, Costacou T, Strotmeyer E, Orchard TJ, (2011) The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: a comparison of methodologies from the Pittsburgh Epidemiology of Diabetes Complications Cohort. Diabetes Res Clin Pract 92: 280-287.
7. Baba M, (2002) Hyperesthesia: an early manifestation of diabetic polyneuropathy. Intern Med 41: 1079-1080.
8. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M, (2003) The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60: 108-111.
9. Smith AG, Singleton JR, (2008) Impaired glucose tolerance and neuropathy. Neurologist 14: 23-29.
10. England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, et al. (2009) Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 72: 177-184.
11. Perkins BA, Bril V, (2003) Diabetic neuropathy: a review emphasizing diagnostic methods. Clin Neurophysiol 114: 1167-1175.
12. Perkins BA, Orszag A, Ngo M, Ng E, Nwe P, et al. (2010) Prediction of Incident Diabetic Neuropathy Using the Monofilament Examination: A 4-year prospective study. Diabetes Care 33: 1549-1554.
13. Perkins BA, Olaleye D, Zinman B, Bril V, (2001) Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 24: 250-256.
14. Olaleye D, Perkins BA, Bril V, (2001) Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract 54: 115-128.
15. Krishnan ST, Rayman G, (2004) The LDIflare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes. Diabetes Care 27: 2930-2935.
16. Krishnan ST, Quattrini C, Jeziorska M, Malik RA, Rayman G, (2009) Abnormal LDIflare but normal quantitative sensory testing and dermal nerve fiber density in patients with painful diabetic neuropathy. Diabetes Care 32: 451-455.
17. Lin Q, Wu J, Willis WD, (1999) Dorsal root reflexes and cutaneous neurogenic inflammation after intradermal injection of capsaicin in rats. J Neurophysiol 82: 2602-2611.
18. Schmelz M, Michael K, Weidner C, Schmidt R, Torebjork HE, et al. (2000) Which nerve fibers mediate the axon reflex flare in human skin? Neuroreport 11: 645-648.
19. Green AQ, Krishnan ST, Rayman G, (2009) C-fiber function assessed by the laser doppler imager flare technique and acetylcholine iontophoresis. Muscle Nerve 40: 985-991.
20. Bril V, Perkins BA, (2002) Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 25: 2048-2052.
21. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, et al. (2005) Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 64: 199-207.
22. Oh SJ, (2002) Normal values for common nerve conduction tests. Clinical Electromyography Nerve Conduction Studies. 3rd ed. Baltimore: Lippincott Williams & Wilkins pp. 86-106.
23. Hossain P, Sachdev A, Malik RA, (2005) Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet 366: 1340-1343.
24. Quadrado MJ, Popper M, Morgado AM, Murta JN, Van Best JA, (2006) Diabetes and corneal cell densities in humans by in vivo confocal microscopy. Cornea 25: 761-768.
25. Quattrini C, Tavakoli M, Jeziorska M, Kallinikos P, Tesfaye S, et al. (2007) Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 56: 2148-2154.
26. Tavakoli M, Malik RA, (2011) Corneal confocal microscopy: a novel non-invasive technique to quantify small fibre pathology in peripheral neuropathies. J Vis Exp 47: 2194-3001.
27. Kahn R, (1992) Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Quantitative sensory testing. Diabetes Care 15: 1092-1094.
28. Yarnitsky D, (1997) Quantitative sensory testing. Muscle Nerve 20: 198-204.
29. Zinman LH, Bril V, Perkins BA, (2004) Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instruments. Diabetes Care 27: 1674-1679.
30. Caselli A, Spallone V, Marfia GA, Battista C, Pachatz C, et al. (2006) Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction. J Neurol Neurosurg Psychiatry 77: 927-932.
31. Green AQ, Krishnan S, Finucane FM, Rayman G, (2010) Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance. Diabetes Care 33: 174-176.
32. Bornmyr S, Castenfors J, Svensson H, Wroblewski M, Sundkvist G, et al. (1999) Detection of autonomic sympathetic dysfunction in diabetic patients. A study using laser Doppler imaging. Diabetes Care 22: 593-597.
33. Vinik AI, Bril V, Litchy WJ, Price KL, Bastyr EJ 3rd, (2005) Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy. Muscle Nerve 32: 619-625.
34. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. (2009) Diabetes Care 32: 1327-1334.
35. Krishnan ST, Quattrini C, Jeziorska M, Malik RA, Rayman G, (2007) Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects. Diabetes Care 30: 3058-3062.